A detailed history of Walleye Trading LLC transactions in Novavax Inc stock. As of the latest transaction made, Walleye Trading LLC holds 137,500 shares of NVAX stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
137,500
Previous 127,600 7.76%
Holding current value
$1.28 Million
Previous $1.62 Million 7.49%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.71 - $17.11 $373,286 - $596,351
-34,854 Reduced 95.78%
1,536 $19,000
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $141,557 - $763,098
36,390 New
36,390 $460,000
Q3 2023

Nov 14, 2023

BUY
$6.81 - $9.74 $106,944 - $152,956
15,704 New
15,704 $113,000
Q2 2022

Aug 08, 2022

BUY
$36.28 - $75.29 $45,313 - $94,037
1,249 Added 90.57%
2,628 $135,000
Q2 2020

Aug 14, 2020

BUY
$13.86 - $83.61 $19,112 - $115,298
1,379 New
1,379 $115,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $729M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.